Amalgamated Bank Neogenomics Inc Transaction History

Amalgamated Bank

$12.1 Billion
Q3 2024

A detailed history of Amalgamated Bank transactions in Neogenomics Inc stock. As of the latest transaction made, Amalgamated Bank holds 38,006 shares of NEO stock, worth $652,943. This represents 0.0% of its overall portfolio holdings.

Number of Shares

38,006

Previous 39,010 2.57%

Holding current value

$652,943

Previous $541,000 3.7%

% of portfolio

0.0%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 30, 2024	SELL	$13.4 - $17.73 $13,453 - $17,800	-1,004 Reduced 2.57%	38,006 $561,000
Q2 2024 Aug 12, 2024	SELL	$13.01 - $15.77 $19,684 - $23,860	-1,513 Reduced 3.73%	39,010 $541,000
Q1 2024 Apr 23, 2024	SELL	$14.06 - $16.79 $109,949 - $131,297	-7,820 Reduced 16.18%	40,523 $637,000
Q4 2023 Feb 06, 2024	SELL	$11.67 - $20.73 $20,737 - $36,837	-1,777 Reduced 3.55%	48,343 $782,000
Q3 2023 Nov 08, 2023	SELL	$12.15 - $17.85 $20,120 - $29,559	-1,656 Reduced 3.2%	50,120 $616,000
Q2 2023 Aug 11, 2023	SELL	$14.1 - $19.83 $17,907 - $25,184	-1,270 Reduced 2.39%	51,776 $832,000
Q1 2023 May 02, 2023	SELL	$9.09 - $19.45 $38,877 - $83,187	-4,277 Reduced 7.46%	53,046 $924,000
Q4 2022 Feb 10, 2023	BUY	$6.45 - $12.07 $2,618 - $4,900	406 Added 0.71%	57,323 $530,000
Q3 2022 Nov 09, 2022	BUY	$7.86 - $12.91 $6,767 - $11,115	861 Added 1.54%	56,917 $490,000
Q2 2022 Aug 15, 2022	SELL	$7.06 - $13.97 $23,283 - $46,073	-3,298 Reduced 5.56%	56,056 $457,000
Q1 2022 Jun 30, 2022	SELL	$12.15 - $35.28 $27,993 - $81,285	-2,304 Reduced 3.74%	59,354 $721,000
Q4 2021 Feb 15, 2022	SELL	$30.49 - $48.49 $38,447 - $61,145	-1,261 Reduced 2.0%	61,658 $2.1 Million
Q3 2021 Oct 29, 2021	SELL	$41.66 - $52.52 $4,915 - $6,197	-118 Reduced 0.19%	62,919 $3.04 Million
Q2 2021 Aug 16, 2021	BUY	$36.62 - $51.69 $1.7 Million - $2.41 Million	46,559 Added 282.55%	63,037 $2.85 Million
Q1 2021 May 13, 2021	SELL	$41.56 - $59.88 $36,157 - $52,095	-870 Reduced 5.01%	16,478 $795,000
Q4 2020 Feb 12, 2021	BUY	$36.08 - $56.47 $12,844 - $20,103	356 Added 2.1%	17,348 $934,000
Q3 2020 Oct 30, 2020	SELL	$33.26 - $40.48 $18,559 - $22,587	-558 Reduced 3.18%	16,992 $627,000
Q2 2020 Aug 10, 2020	SELL	$24.21 - $31.02 $15,445 - $19,790	-638 Reduced 3.51%	17,550 $544,000
Q1 2020 May 13, 2020	SELL	$20.5 - $34.53 $16,994 - $28,625	-829 Reduced 4.36%	18,188 $502,000
Q4 2019 Feb 13, 2020	BUY	$18.96 - $29.84 $51,476 - $81,015	2,715 Added 16.65%	19,017 $556,000
Q3 2019 Nov 13, 2019	SELL	$19.12 - $26.24 $4,913 - $6,743	-257 Reduced 1.55%	16,302 $312,000
Q2 2019 Aug 14, 2019	BUY	$19.57 - $24.1 $75,403 - $92,857	3,853 Added 30.32%	16,559 $363,000
Q1 2019 May 15, 2019	BUY	$12.14 - $20.46 $154,250 - $259,964	12,706 New	12,706 $260,000

Others Institutions Holding NEO

# of Institutions

295

Shares Held

125M

Call Options Held

698K

Put Options Held

120K

View Full List

About NEOGENOMICS INC

Ticker NEO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 125,796,000
Market Cap $2.16B
Description
NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...

More about NEO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Amalgamated Bank, based on Form 13F filings with the SEC.

News

Stay updated on Amalgamated Bank with notifications on news.

Account

Amalgamated Bank Neogenomics Inc Transaction History